C85.86 Other specified types of non-Hodgkin lymphoma, intrapelvic lymph nodes

Name of the Condition

• Other specified types of non-Hodgkin lymphoma, intrapelvic lymph nodes
• C85.86

Summary

Non-Hodgkin lymphoma (NHL) is a group of blood cancers affecting the lymphatic system. This code represents NHL types that do not fit into more specific subcategories and are explicitly documented as "other specified" in clinical records, with involvement of the intrapelvic lymph nodes. The lymphatic system, part of the immune system, is involved in fighting infections, and NHL arises from abnormal lymphocyte growth.

Causes

The exact cause of non-Hodgkin lymphoma is often unknown but involves genetic mutations in lymphocytes. Factors such as viral infections (e.g., Epstein-Barr virus), immune system disorders, or exposure to certain chemicals may contribute to its development. These mutations disrupt normal cell regulation, leading to uncontrolled growth.

Risk Factors

• Advanced age (more common in older adults)
• Weakened immune system (e.g., HIV/AIDS, immunosuppressive therapy)
• Certain infections (e.g., hepatitis C, H. pylori)
• Exposure to chemicals (e.g., pesticides, herbicides)
• Family history of lymphoma
• Autoimmune conditions (e.g., rheumatoid arthritis)

Symptoms

• Swollen lymph nodes (neck, armpits, groin)
• Fever, night sweats, or unexplained weight loss
• Fatigue or weakness
• Abdominal pain or swelling
• Persistent cough or chest discomfort
• Itching or skin rashes

Diagnosis

Diagnosis typically involves a physical exam to check for swollen lymph nodes, blood tests to assess blood cell levels, imaging tests like CT or PET scans, and potentially a biopsy to examine lymphatic tissue. The specific location of lymph node involvement, such as intrapelvic, is documented to guide further evaluation.

Treatment Options

Treatment depends on the specific type and progression of the lymphoma and may include chemotherapy, radiation therapy, immunotherapy, or targeted therapy. The choice of treatment considers factors like the patient’s overall health and the extent of disease.

Prognosis and Follow-Up

Prognosis varies based on the lymphoma type, stage, and patient factors. Regular follow-up appointments are essential to monitor for recurrence or treatment-related side effects. Long-term surveillance may be recommended to detect any changes early.

Complications

Potential complications include infection due to a weakened immune system, organ damage from tumor growth, or side effects from treatment such as fatigue, nausea, or increased risk of other cancers.

Lifestyle & Prevention

Maintaining a healthy lifestyle, including a balanced diet, regular exercise, and avoiding known risk factors like excessive alcohol or tobacco use, may support overall health. Preventing infections through vaccination and hygiene practices is also important.

When to Seek Professional Help

Seek medical attention if you experience persistent symptoms like unexplained weight loss, fever, night sweats, or swollen lymph nodes. Early evaluation is crucial for timely diagnosis and management.

Tips for Medical Coders

When coding C85.86, ensure the clinical documentation specifies "other specified types of non-Hodgkin lymphoma" and clearly identifies involvement of intrapelvic lymph nodes. Verify that the diagnosis aligns with the anatomical site and that no more specific lymphoma code applies. Accurate documentation of the lymph node location is essential for correct code assignment.